RxSight, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1281046,
    "name": "RxSight, Inc.",
    "stock_name": "RxSight, Inc.",
    "full_name": "RxSight, Inc.",
    "name_url": "stocks-analysis/rxsight-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "12.49",
    "chg": 0.73,
    "chgp": "6.21%",
    "dir": 1,
    "prev_price": "11.76",
    "mcapval": "365.79",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Electronics & Appliances",
    "ind_code": 1310,
    "indexname": "S&P 500",
    "isin": "US78349D1072",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.01 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rxsight-inc-1281046-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is RxSight, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rxsight-inc-technically-bullish-or-bearish-3547139",
        "imagepath": "",
        "date": "2025-09-20 19:48:00",
        "description": "As of 5 September 2025, the technical trend for RxSight, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The Bollinger Bands and moving averages are both showing mildly bearish signals on the weekly and daily time frames. The KST is mildly bullish weekly but bearish monthly, and the Dow Theory indicates no trend on the weekly but mildly bearish on the monthly. \n\nIn terms of performance, RxSight has underperformed significantly compared to the S&P 500, with a year-to-date return of -72.4% versus the S&P 500's 12.22%, and a one-year return of -82.48% compared to 17.14%. Overall, the current technical stance is mildly bearish, driven by mixed signals across various indicators...."
      },
      {
        "title": "Is RxSight, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rxsight-inc-overvalued-or-undervalued-3543570",
        "imagepath": "",
        "date": "2025-09-20 18:22:57",
        "description": "As of 10 November 2021, the valuation grade for RxSight, Inc. has moved from does not qualify to risky, indicating a deterioration in its investment profile. The company appears to be overvalued given its negative financial metrics, including a Price to Book Value of 2.19, an EV to Sales ratio of 2.58, and an EV to EBITDA of -11.40. Comparatively, Methode Electronics, Inc. has a more favorable EV to EBITDA of 13.0540, highlighting RxSight's relative weakness in valuation.\n\nThe company’s recent stock performance has been poor, with a year-to-date return of -72.4% compared to the S&P 500's positive return of 12.22%. This stark contrast reinforces the notion that RxSight, Inc. is currently overvalued in the market...."
      }
    ],
    "total": 6,
    "sid": "1281046",
    "stock_news_url": "https://www.marketsmojo.com/news/rxsight-inc-1281046"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is RxSight, Inc. technically bullish or bearish?

2025-09-20 19:48:00

As of 5 September 2025, the technical trend for RxSight, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The Bollinger Bands and moving averages are both showing mildly bearish signals on the weekly and daily time frames. The KST is mildly bullish weekly but bearish monthly, and the Dow Theory indicates no trend on the weekly but mildly bearish on the monthly. In terms of performance, RxSight has underperformed significantly compared to the S&P 500, with a year-to-date return of -72.4% versus the S&P 500's 12.22%, and a one-year return of -82.48% compared to 17.14%. Overall, the current technical stance is mildly bearish, driven by mixed signals across various indicators....

Is RxSight, Inc. overvalued or undervalued?

2025-09-20 18:22:57

As of 10 November 2021, the valuation grade for RxSight, Inc. has moved from does not qualify to risky, indicating a deterioration in its investment profile. The company appears to be overvalued given its negative financial metrics, including a Price to Book Value of 2.19, an EV to Sales ratio of 2.58, and an EV to EBITDA of -11.40. Comparatively, Methode Electronics, Inc. has a more favorable EV to EBITDA of 13.0540, highlighting RxSight's relative weakness in valuation. The company’s recent stock performance has been poor, with a year-to-date return of -72.4% compared to the S&P 500's positive return of 12.22%. This stark contrast reinforces the notion that RxSight, Inc. is currently overvalued in the market....

View All News